Science and Research

[Antibiotic treatment of community-acquired and hospital-acquired pneumonia]

Community-acquired and nosocomial bacterial pneumonia are among the most common infectious diseases in Germany. Knowledge of possible pathogens and therapeutic implications thereof are essential to be able to provide adequate, differentiated antimicrobial therapy with the appropriate drugs, form of application, dose, and duration. New diagnostics that include multiplex polymerase chain reaction, correct interpretation of the biomarker procalcitonin, and treatment of multidrug-resistant bacteria are becoming increasingly import.

  • Simon, S.
  • Rademacher, J.

Keywords

  • Community-acquired pneumonia (CAP)
  • Duration of therapy
  • Hospital-acquired pneumonia (HAP)
  • Multiplex PCR
  • Severe community-acquired pneumonia
Publication details
DOI: 10.1007/s00063-023-01033-8
Journal: Med Klin Intensivmed Notfmed
Work Type: Review
Location: BREATH
Disease Area: PALI
Partner / Member: MHH
Access-Number: 37405418

DZL Engagements

chevron-down